126 related articles for article (PubMed ID: 6435895)
1. CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs.
Levin VA; Byrd D; Campbell J; Davis RL; Borcich JK
Cancer Chemother Pharmacol; 1984; 13(3):200-5. PubMed ID: 6435895
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
[TBL] [Abstract][Full Text] [Related]
3. Antigrowth effect of polyamine biosynthesis inhibitors on the Dunning R 3327-G prostatic tumor.
Herr HW; Kleinert EL
Prostate; 1984; 5(4):439-44. PubMed ID: 6429652
[TBL] [Abstract][Full Text] [Related]
4. [Anticancer treatment with a combination of antimetabolites of polyamine and pyrimidine].
Fujimoto S; Shrestha RD; Igarashi K; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Ohta M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2024-9. PubMed ID: 2932057
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
Herr HW; Kleinert EL; Relyea NM; Whitmore WF
Cancer; 1984 Mar; 53(6):1294-8. PubMed ID: 6420041
[TBL] [Abstract][Full Text] [Related]
6. Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
Dunzendorfer U; Relyea NM; Kleinert E; Balis ME; Whitmore WF
Oncology; 1983; 40(1):57-62. PubMed ID: 6401860
[TBL] [Abstract][Full Text] [Related]
7. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice.
Kramer DL; Paul B; Porter CW
Cancer Res; 1985 Jun; 45(6):2512-5. PubMed ID: 3921245
[TBL] [Abstract][Full Text] [Related]
8. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
9. Combined use of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in normal and leukemia-bearing mice.
Seppänen P; Alhonen-Hongisto L; Jänne J
Cancer Lett; 1983 Feb; 18(1):1-10. PubMed ID: 6402294
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of two polyamine antimetabolites combined with mitomycin C on human stomach cancer cells xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Okui K
Int J Cancer; 1985 Jun; 35(6):821-5. PubMed ID: 3924844
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and ultrastructural characterization of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
Kramer DL; Zychlinski L; Wiseman A; Porter CW
Cancer Res; 1983 Dec; 43(12 Pt 1):5943-50. PubMed ID: 6416670
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Endoh F; Ohta M; Togawa Y; Okui K
Jpn J Surg; 1986 Mar; 16(2):133-9. PubMed ID: 2941608
[TBL] [Abstract][Full Text] [Related]
13. Regulation of epidermal proliferation in mouse epidermis by combination of difluoromethyl ornithine (DFMO) and methylglyoxal bis(guanylhydrazone) (MGBG).
McCullough JL; Peckham P; Klein J; Weinstein GD; Jenkins JJ
J Invest Dermatol; 1985 Dec; 85(6):518-21. PubMed ID: 3934288
[TBL] [Abstract][Full Text] [Related]
14. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
Dunzendorfer U; Knöner M
Onkologie; 1985 Aug; 8(4):196-200. PubMed ID: 2419811
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effects of polyamine synthesis inhibitors based on major premise of treatment for human malignant tumor].
Fujimoto S; Shrestha RD; Igarashi K; Terao K; Hirose S; Okui K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1778-84. PubMed ID: 6820883
[TBL] [Abstract][Full Text] [Related]
16. [Combined therapy with polyamine biosynthesis inhibitors and mitomycin C].
Fujimoto S; Shrestha RD; Igarashi K; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Ohta M
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1257-62. PubMed ID: 6428324
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antileukemic effect of two polyamine synthesis inhibitors. Host survival and cell-cycle kinetic analysis.
Ask A; Persson L; Oredsson SM; Heby O
Int J Cancer; 1986 Mar; 37(3):465-70. PubMed ID: 3081454
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous penetration of methylglyoxal bis(guanylhydrazone): effects on hairless mouse epidermis in vivo.
McCullough JL; Weinstein GD; Rosenblum MG; Jenkins JJ
J Invest Dermatol; 1983 Nov; 81(5):388-92. PubMed ID: 6415178
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.
Herr HW; Warrel RP; Burchenal JH
Urology; 1986 Dec; 28(6):508-11. PubMed ID: 3097903
[TBL] [Abstract][Full Text] [Related]
20. Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].
Warrell RP; Coonley CJ; Burchenal JH
Cancer Chemother Pharmacol; 1983; 11(2):134-6. PubMed ID: 6414731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
